Biochemical and behavioral effects of rosmarinic acid treatment in an animal model of Parkinson’s disease induced by MPTP

This publication has 48 references indexed in Scilit:

• Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
  Trends in Neurosciences, 2013
• Function of Plectranthus barbatus herbal tea as neuronal acetylcholinesterase inhibitor
  Food & Function, 2010
• Rosmarinic Acid Antagonized 1-Methyl-4-Phenylpyridinium (MPP⁺)-Induced Neurotoxicity in MES23.5 Dopaminergic Cells
  International Journal of Toxicology, 2010
• Iron deficiency alters dopamine uptake and response to L‐DOPA injection in Sprague–Dawley rats
  Journal of Neurochemistry, 2008
• Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
  Proceedings of the National Academy of Sciences, 2007
• Rosmarinic acid
  Phytochemistry, 2003
• The ?2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions ofL-dopa in the MPTP-lesioned primate model of Parkinson's disease
  Movement Disorders, 1999
• Neuropathology in movement disorders.
  Journal of Neurology, Neurosurgery & Psychiatry, 1989
• Assessment of chemically-induced changes in the neuromuscular function of rats using a new recording grip meter
  Life Sciences, 1978
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976